Structures by: Delori A.
Total: 59
Triamterene, succinic acid and DMSO
C12H12N71,C4H5O41,C2H6OS
IUCrJ (2018) 5, 3
a=13.5226(7)Å b=14.9966(7)Å c=10.6958(5)Å
α=90° β=104.179(2)° γ=90°
Triamterene, acetic acid and DMSO
C12H12N71,C2H6OS,C2H3O21
IUCrJ (2018) 5, 3
a=10.8022(2)Å b=13.9084(2)Å c=14.6076(3)Å
α=115.2840(10)° β=109.088(2)° γ=90.5250(10)°
Triamterene, adipic acid and DMSO
2(C12H12N7),C6H8O4,2(C2H6OS)
IUCrJ (2018) 5, 3
a=11.0286(3)Å b=13.7429(4)Å c=14.9742(5)Å
α=115.247(2)° β=109.951(4)° γ=90.122(2)°
Triamterene, azelaic acid and DMSO
2(C12H12N71),C9H14O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=15.0338(3)Å b=11.5004(2)Å c=24.3960(6)Å
α=90° β=104.5390(10)° γ=90°
Triamterene, pimelic acid and DMSO
2(C12H12N71),C7H10O42,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.0750(5)Å b=14.8889(6)Å c=19.635(2)Å
α=86.408(2)° β=88.142(3)° γ=71.702(2)°
Triamterene, nicotinic acid and DMSO
C12H12N71,C12H11N7,C6H4NO21,2(C2H6OS)
IUCrJ (2018) 5, 3
a=14.8461(2)Å b=12.3081(3)Å c=21.2850(5)Å
α=90° β=105.1760(10)° γ=90°
Triamterene and Ibuprofen salt, DMSO solvate
C12H12N71,C12H11N7,C13H17O21,C2H6OS
IUCrJ (2018) 5, 3
a=11.2398(3)Å b=13.2439(3)Å c=15.4624(4)Å
α=113.595(2)° β=103.527(3)° γ=91.977(2)°
Triamterene
C12H11N7
Chemistry Central Journal (2017) 63, 11
a=7.4432(15)Å b=9.993(2)Å c=16.648(3)Å
α=77.55(2)° β=87.54(3)° γ=87.09(3)°
Trimethoprim+2-aminoterephthalic acid
2(C14H18N4O3),C8H7N1O4
CrystEngComm (2011) 13, 21 6315
a=9.19770(10)Å b=8.25530(10)Å c=23.7783(4)Å
α=90.00° β=96.1930(10)° γ=90.00°
Coumarin-3-carboxylic acid+4,4'-bipyridylethane
C12H12N2,2(C10H6O4)
CrystEngComm (2012) 14, 16 5121
a=16.3933(6)Å b=4.8921(2)Å c=16.5326(8)Å
α=90.00° β=103.209(2)° γ=90.00°
Coumarin-3-carboxylic acid+pyridine-2,6-diamine
C10H5O4,C5H8N3
CrystEngComm (2012) 14, 16 5121
a=13.8797(2)Å b=12.9776(5)Å c=7.3847(6)Å
α=90.00° β=90.383(2)° γ=90.00°
Pyrimethaminium+saccharinate+methanol
C12H14ClN41,C7H4NO3S1,CH4O
CrystEngComm (2013) 15, 15 2916
a=6.90400(10)Å b=7.58660(10)Å c=21.2823(3)Å
α=85.3640(10)° β=81.0520(10)° γ=79.0070(10)°
Pyrimethamine+theophylline
C12H13ClN4,C7H8N4O2
CrystEngComm (2013) 15, 15 2916
a=7.9789(4)Å b=10.3092(5)Å c=13.6586(7)Å
α=68.186(3)° β=87.884(2)° γ=75.726(3)°
Pyrimethaminium+aspirinate+acetonitrile
C12H14ClN41,C9H7O41,C2H3N
CrystEngComm (2013) 15, 15 2916
a=10.0012(3)Å b=11.5494(4)Å c=11.7171(4)Å
α=107.432(2)° β=106.355(2)° γ=99.557(2)°
Pyrimethaminium+p-coumarate+water
C12H14ClN41,C9H7O31,H2O
CrystEngComm (2013) 15, 15 2916
a=7.60860(10)Å b=9.9450(2)Å c=14.6138(3)Å
α=80.9630(10)° β=87.2240(10)° γ=72.8160(10)°
N-Phenyl-p-phenylenediamine+diglycolic acid
C12H12N2,C4H6O5
CrystEngComm (2016) 18, 28 5360
a=17.9195(15)Å b=9.1323(8)Å c=18.7653(15)Å
α=90° β=90° γ=90°
N-Phenyl-p-phenylenediamine+diglycolic acid
C12H12N2,C4H6O5
CrystEngComm (2016) 18, 28 5360
a=19.0949(19)Å b=9.2904(9)Å c=17.9875(19)Å
α=90° β=110.543(5)° γ=90°
1,4-Diaminobenzene+lawsone
2(C10H5O3),C6H10N2
CrystEngComm (2016) 18, 28 5360
a=14.204(3)Å b=8.573(2)Å c=8.3934(19)Å
α=90° β=91.851(13)° γ=90°
1,4-Diaminobenzene+sebacic acid
C10H16O4,2(C6H9N2)
CrystEngComm (2016) 18, 28 5360
a=9.1366(7)Å b=6.2639(6)Å c=20.6631(16)Å
α=90.00° β=94.489(5)° γ=90.00°
1,4-Diaminobenzene+trimesic acid+methanol
C9H5O6,C6H9N2,CH4O
CrystEngComm (2016) 18, 28 5360
a=3.9902(2)Å b=17.0520(9)Å c=23.5518(12)Å
α=90° β=90° γ=90°
Coumarin-3-carboxylic acid+4,4'-bipyridine
2(C10H6O4),C10H8N2
CrystEngComm (2012) 14, 16 5121
a=3.90990(10)Å b=20.2636(3)Å c=15.3093(3)Å
α=90.00° β=91.3460(10)° γ=90.00°
Coumarin-3-carboxylic acid+4,4'-bipyridylethene
C12H10N2,2(C10H6O4)
CrystEngComm (2012) 14, 16 5121
a=16.2227(4)Å b=5.02570(10)Å c=16.3150(5)Å
α=90.00° β=100.9180(10)° γ=90.00°
Pyrimethaminium+alpha-ketoglutarate
C12H14ClN41,C5H5O51
CrystEngComm (2013) 15, 15 2916
a=7.8393(2)Å b=11.0472(3)Å c=12.1060(4)Å
α=82.881(2)° β=71.670(2)° γ=69.719(2)°
Lawsone-bipyridyl
2(C10H6O3),C10H8N2
CrystEngComm (2015) 17, 40 7684
a=10.6360(3)Å b=4.7798(1)Å c=23.0987(9)Å
α=90.00° β=96.131(2)° γ=90.00°
Lawsone-ethylenebipyridine
C12H12N22,2(C10H5O31)
CrystEngComm (2015) 17, 40 7684
a=3.8157(1)Å b=28.0772(7)Å c=11.2326(3)Å
α=90.00° β=96.542(2)° γ=90.00°
Lawsone-trimethylenebipyridine
C13H14N2,2(C10H6O3)
CrystEngComm (2015) 17, 40 7684
a=22.5402(9)Å b=50.511(2)Å c=4.6451(2)Å
α=90.00° β=90.00° γ=90.00°
Lawsone-hydroxypyridine
C15H11NO4
CrystEngComm (2015) 17, 40 7684
a=13.6937(12)Å b=5.1534(3)Å c=17.5288(12)Å
α=90° β=92.329(7)° γ=90°
2,4-Diamino-6-phenyl-1,3,5-triazine+1,3-Phenylenediacetic acid
C10H10O4,2(C9H9N5)
CrystEngComm (2013) 15, 24 4811
a=31.500(7)Å b=12.412(3)Å c=7.016(2)Å
α=90.00° β=90.00° γ=90.00°
2,4-Diamino-6-phenyl-1,3,5-triazine+Isophthalic Acid
C9H9N5,C8H6O4
CrystEngComm (2013) 15, 24 4811
a=8.504(6)Å b=10.199(7)Å c=10.258(7)Å
α=108.530(10)° β=91.790(10)° γ=92.960(10)°
2,4-Diamino-6-phenyl-1,3,5-triazine+1,4-Phenylenediacetic acid
2(C9H9N5),C10H10O4
CrystEngComm (2013) 15, 24 4811
a=12.405(4)Å b=6.948(2)Å c=31.402(11)Å
α=90.00° β=90.00° γ=90.00°
2,4-Diamino-6-phenyl-1,3,5-triazine+terephthalic acid
2(C9H9N5),C8H6O4
CrystEngComm (2013) 15, 24 4811
a=29.9430(10)Å b=7.007(2)Å c=12.152(4)Å
α=90.00° β=107.780(10)° γ=90.00°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=10.0093(3)Å b=22.8207(8)Å c=10.4016(4)Å
α=90° β=91.416(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1345(7)Å b=23.048(3)Å c=7.4330(8)Å
α=90° β=90.449(6)° γ=90°
30:70 (+-)-4'-methylmethcathinone hydrochloride hydrobromide salt solution
C11H16NO,0.72(Br),0.28(Cl)
CrystEngComm (2014) 16, 26 5827
a=10.2017(6)Å b=22.3376(13)Å c=10.5639(6)Å
α=90° β=90.157(3)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=10.0604(18)Å b=22.876(4)Å c=10.4041(19)Å
α=90° β=91.741(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=9.9973(13)Å b=22.788(3)Å c=10.4078(14)Å
α=90° β=91.2430(10)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1160(12)Å b=22.916(4)Å c=7.3818(13)Å
α=90° β=91.415(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1234(14)Å b=22.966(4)Å c=7.3986(14)Å
α=90° β=91.146(2)° γ=90°
(+-)-4'-methylmethcathinone hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1264(14)Å b=22.986(5)Å c=7.4072(14)Å
α=90° β=90.974(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1314(14)Å b=23.013(5)Å c=7.4180(15)Å
α=90° β=90.803(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrochloride, Mephedrone
C11H16NO,Cl
CrystEngComm (2014) 16, 26 5827
a=7.1365(14)Å b=23.041(5)Å c=7.4304(15)Å
α=90° β=90.628(2)° γ=90°
(+-)-4'-methylmethcathinone Hydrobromide
C11H16NO,Br
CrystEngComm (2014) 16, 26 5827
a=5.7804(4)Å b=19.7971(14)Å c=10.5967(6)Å
α=90° β=100.841(3)° γ=90°
(+-)-4'-methylmethcathinone Hydrobromide
C11H16NO,Br
CrystEngComm (2014) 16, 26 5827
a=10.8355(19)Å b=10.2030(17)Å c=11.5425(19)Å
α=90° β=111.839(8)° γ=90°
60:40 (+-)-4'-methylmethcathinone hydrochloride hydrobromide salt solution
C11H16NO,0.4(Br),0.6(Cl)
CrystEngComm (2014) 16, 26 5827
a=10.1409(11)Å b=22.488(3)Å c=10.4979(11)Å
α=90° β=90.359(8)° γ=90°
70:30 (+-)-4'-methylmethcathinone hydrochloride hydrobromide salt solution
C11H16Br0.30Cl0.70N1O1
CrystEngComm (2014) 16, 26 5827
a=10.1012(5)Å b=22.5506(12)Å c=10.4737(5)Å
α=90° β=90.441(3)° γ=90°
1,4-Dioxane-2,5-dione
C4H4O4
CrystEngComm (2015) 17, 8 1778
a=6.7039(2)Å b=14.9481(4)Å c=9.6177(2)Å
α=90° β=98.9365(18)° γ=90°
1,4-Dioxane-2,5-dione
C4H4O4
CrystEngComm (2015) 17, 8 1778
a=5.2399(2)Å b=7.4388(3)Å c=11.7763(4)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=9.4272(2)Å b=7.0774(2)Å c=18.2519(4)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=9.1478(3)Å b=6.9826(3)Å c=17.6799(4)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=8.8661(5)Å b=6.9379(4)Å c=17.120(3)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=8.4895(2)Å b=6.8759(2)Å c=16.6225(14)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=8.4043(2)Å b=6.8578(2)Å c=16.5271(12)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=8.3242(4)Å b=6.8403(3)Å c=16.447(2)Å
α=90° β=90° γ=90°
C11H16NO2,Cl
C11H16NO2,Cl
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials (2015) 71, 1
a=8.3325(8)Å b=6.814(2)Å c=16.4416(16)Å
α=90° β=90° γ=90°
2(C21H17N21),C4F4O42,2(H2O)
2(C21H17N21),C4F4O42,2(H2O)
Crystal Growth & Design (2013) 13, 1 333
a=8.6090(1)Å b=10.7972(2)Å c=12.1225(2)Å
α=109.500(1)° β=109.517(1)° γ=94.035(1)°
C21H17N2,C7BrF4O2
C21H17N2,C7BrF4O2
Crystal Growth & Design (2013) 13, 1 333
a=8.1916(1)Å b=23.5372(5)Å c=12.5644(3)Å
α=90.00° β=104.577(1)° γ=90.00°
Pyrimethamine+carbamazepine+methanol
C15H12N2O,C12H13ClN4,2(CH4O)
CrystEngComm (2013) 15, 15 2916
a=7.96900(10)Å b=10.11220(10)Å c=17.9406(3)Å
α=92.9360(10)° β=94.1630(10)° γ=106.0620(10)°
2,4-Diamino-6-phenyl-1,3,5-triazine+Phthalic Acid
C9H10N5,C8H5O4
CrystEngComm (2013) 15, 24 4811
a=7.162(2)Å b=10.042(2)Å c=12.835(3)Å
α=68.270(10)° β=85.450(10)° γ=71.460(10)°
2,4-Diamino-6-phenyl-1,3,5-triazine+benzoic acid
C9H9N5,C7H6O2
CrystEngComm (2013) 15, 24 4811
a=9.821(3)Å b=7.135(2)Å c=12.126(2)Å
α=90.00° β=116.60(2)° γ=90.00°